Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC (HKMPY) Revenue
Annual & quarterly revenue history · segment & region breakdown
HKMPY · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsHikma Pharmaceuticals PLC trailing twelve-month (TTM) revenue is $6.47B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare HKMPY revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Hikma Pharmaceuticals PLC receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Hikma Pharmaceuticals PLC reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Hikma Pharmaceuticals PLC's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HKMPY revenue · 4 questionsHKMPY's trailing twelve-month (TTM) revenue is $6.47B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Hikma Pharmaceuticals PLC SEC filings · GAAP · Hikma Pharmaceuticals PLC SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026